Medicines

Fulltext search

For help on how to get the results you want, see our search tips.

Search results

Categories

Human (2) Apply Human filter

Medicine name

Active substance / international non-proprietary name (INN) / common name

Medicine

European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter Referrals Remove Referrals filter

Product number

Date of opinion

From:

To:

Referral name

Referral status

Opinion provided by Committee for Medicinal Products for Human Use Remove Opinion provided by Committee for Medicinal Products for Human Use filter Under evaluation Remove Under evaluation filter European Commission final decision (145) Apply European Commission final decision filter CMDh final position (15) Apply CMDh final position filter Procedure started (1) Apply Procedure started filter

Referral safety status

Yes (1) Apply Yes filter

Referral type

Article 20 procedures Remove Article 20 procedures filter Article 31 referrals Remove Article 31 referrals filter Article 13 Remove Article 13 filter Article 13 referrals Remove Article 13 referrals filter Articles 39 and 40 Remove Articles 39 and 40 filter Article 29(4) referrals (2) Apply Article 29(4) referrals filter Article 82 (2) Apply Article 82 filter Article 30 referrals (1) Apply Article 30 referrals filter

Referral reference number

Referral decision making model

PRAC-CHMP-EC (1) Apply PRAC-CHMP-EC filter PRAC-CMDh (1) Apply PRAC-CMDh filter

Referral authorisation model

Centrally authorised product(s) (1) Apply Centrally authorised product(s) filter Nationally authorised product(s) (1) Apply Nationally authorised product(s) filter

Referral PRAC recommendation

Risk minimisation measures (1) Apply Risk minimisation measures filter

Referral procedure start date

From:

To:

Referral PRAC recommendation date

From:

To:

Medicine type

Additional monitoring (1) Apply Additional monitoring filter

Related medicine

Therapeutic area

Last updated

From:

To:

This week This month Last week Last month

First published

From:

To:

2 results

Remove all filtersRemove all filters

Medicine European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter Referrals Remove Referrals filter

Referral type Articles 39 and 40 Remove Articles 39 and 40 filter Article 13 referrals Remove Article 13 referrals filter Article 13 Remove Article 13 filter Article 31 referrals Remove Article 31 referrals filter Article 20 procedures Remove Article 20 procedures filter

Referral status Opinion provided by Committee for Medicinal Products for Human Use Remove Opinion provided by Committee for Medicinal Products for Human Use filter Under evaluation Remove Under evaluation filter

Sort by

List item

Referral: Janus kinase inhibitors (JAKi) (updated)

tofacitinib, abrocitinib, baricitinib, upadacitinib, filgotinib, associated names: Xeljanz, Cibinqo, Olumiant, Rinvoq, Jyseleca, Article 20 procedures
Status: Opinion provided by Committee for Medicinal Products for Human Use, opinion/position date: 12/01/2023, Last updated: 27/01/2023
List item

Referral: Topiramate

topiramate, Article 31 referrals
Status: Under evaluation, Last updated: 02/12/2022

2 results

Referral: Janus kinase inhibitors (JAKi) (updated)

Referral: Topiramate